Skip to main content
Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · IEX Real-Time Price · USD
37.78
+0.85 (2.30%)
May 1, 2024, 4:00 PM EDT - Market closed

Collegium Pharmaceutical Revenue

In the year 2023, Collegium Pharmaceutical had annual revenue of $566.77M with 22.17% growth. Revenue in the quarter ending December 31, 2023 was $149.75M with 15.53% year-over-year growth.

Revenue (ttm)
$566.77M
Revenue Growth
+22.17%
P/S Ratio
2.13
Revenue / Employee
$2,876,990
Employees
197
Market Cap
1.21B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023566.77M102.83M22.17%
Dec 31, 2022463.93M187.07M67.56%
Dec 31, 2021276.87M-33.15M-10.69%
Dec 31, 2020310.02M13.32M4.49%
Dec 31, 2019296.70M16.29M5.81%
Dec 31, 2018280.41M251.94M884.73%
Dec 31, 201728.48M26.77M1,564.29%
Dec 31, 20161.71M--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ironwood Pharmaceuticals 442.74M
AtriCure 399.25M
Phreesia 356.30M
Mirum Pharmaceuticals 186.37M
Tarsus Pharmaceuticals 17.45M
Spyre Therapeutics 886.00K
Revenue Rankings

COLL News

More News